A qualitative study of governance of evolving response to non-communicable diseases in low-and middle- income countries: current status, risks and options

BMC Public Health

Laura H Hawken³  Sharmin Nusrat²  Manju Rani¹ 

[1] Senior Technical Officer (Health Research Policy), Western Pacific Regional Office, World Health Organization, Manila, Philippines;Princess Alexandra Hospital, 199 Ipswich Road, Brisbane, Queensland, 4102, Australia;Technical officer (Health Services Development), Western Pacific Regional Office, World Health Organization, Manila, Philippines

关键词: Policies;    Governance;    Non-communicable diseases;    Philippines;    Mongolia;    Malaysia;    Fiji;    Cambodia;   

Others  :  1162966
DOI  :  10.1186/1471-2458-12-877

 received in 2012-05-11, accepted in 2012-08-29,  发布年份 2012

【 摘 要 】

Background

Segmented service delivery with consequent inefficiencies in health systems was one of the main concerns raised during scaling up of disease-specific programs in the last two decades. The organized response to NCD is in infancy in most LMICs with little evidence on how the response is evolving in terms of institutional arrangements and policy development processes.

Methods

Drawing on qualitative review of policy and program documents from five LMICs and data from global key-informant surveys conducted in 2004 and 2010, we examine current status of governance of response to NCDs at national level along three dimensions— institutional arrangements for stewardship and program management and implementation; policies/plans; and multisectoral coordination and partnerships.

Results

Several positive trends were noted in the organization and governance of response to NCDs: shift from specific NCD-based programs to integrated NCD programs, increasing inclusion of NCDs in sector-wide health plans, and establishment of high-level multisectoral coordination mechanisms.

Several areas of concern were identified. The evolving NCD-specific institutional structures are being treated as ‘program management and implementation’ entities rather than as lead ‘technical advisory’ bodies, with unclear division of roles and responsibilities between NCD-specific and sector-wide structures. NCD-specific and sector-wide plans are poorly aligned and lack prioritization, costing, and appropriate targets. Finally, the effectiveness of existing multisectoral coordination mechanisms remains questionable.

Conclusions

The ‘technical functions’ and ‘implementation and management functions’ should be clearly separated between NCD-specific units and sector-wide institutional structures to avoid duplicative segmented service delivery systems. Institutional capacity building efforts for NCDs should target both NCD-specific units (for building technical and analytical capacity) and sector-wide organizational units (for building program management and implementation capacity) in MOH.

The sector-wide health plans should reflect NCDs in proportion to their public health importance. NCD specific plans should be developed in close consultation with sector-wide health- and non-health stakeholders. These plans should expand on the directions provided by sector-wide health plans specifying strategically prioritized, fully costed activities, and realistic quantifiable targets for NCD control linked with sector-wide expenditure framework. Multisectoral coordination mechanisms need to be strengthened with optimal decision-making powers and resource commitment and monitoring of their outputs.

【 授权许可】

   
2012 Rani et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]World Health Organization: Preventing chronic diseases; a vital investment; WHO global report. Geneva: World Health Organization; 2005.
• [2]World Health Organization: Global Burden of Disease: 2004 update. Geneva: World Health Organization; 2008.
• [3]Secretariat of the Pacific Community and World Health Organization: Pacific NCD Forum Meeting report. New Caledonia: Secretariat of the Pacific Community and World Health Organization; 2010.
• [4]Biesma RG, et al.: The effects of global health initiatives on country health systems: a review of the evidence from HIV/AIDS control. Health Policy Plan 2009, 24(4):239-52. Epub 2009 Jun 2
• [5]Conseil A, Mounier-Jack S, Coker R: Integration of health systems and priority health interventions: a case study of the integration of HIV and TB control programmes into the general health system in Vietnam. Health Policy Plan 2010, 25(Suppl 1):i32-36.
• [6]Hanefeld J: The impact of Global Health Initiatives at national and sub-national level - a policy analysis of their role in implementation processes of antiretroviral treatment (ART) roll-out in Zambia and South Africa. AIDS 2010, 22(Suppl 1):93-102.
• [7]Samb B, et al.: Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries. Lancet 2010, 376:1785-97.
• [8]Beaglehole R, et al.: Priority actions for the non-communicable disease crisis. Lancet 2011, 377(9775):1438-47. Epub 2011 Apr 5
• [9]Maher D, et al.: A global framework for action to improve the primary care response to chronic non-communicable diseases: a solution to a neglected problem. BMC Publ Health 2009, 9:355. BioMed Central Full Text
• [10]World Health Organization. Geneva: World Health Organization; 2007. [Everyone's business: Strengthening health systems to improve health outcomes: WHO framework for action]
• [11]Hill PS: Understanding global health governance as a complex adaptive system. Glob 2011, 6(6):593-605. Epub 2011 May 24
• [12]Ministry of Health: National Strategy for the Prevention and Control of Non-communicable Disease, Cambodia (2007–2010). Phnom Penh: Department of Preventive Medicine, Ministry of Health; 2007.
• [13]Ministry of Health: Health Strategic Plan 2008–2015. Accountability Efficiency Quality Equity. Kingdom of Cambodia: Ministry of Health, Kingdom of Cambodia; 2008.
• [14]Ministry of Health, Fiji: Non-communicable Diseases Prevention and Control: National Strategic Plan (2010–2014): From womb to tomb with a double edged sword, Everyone’s Business. Fiji: Ministry of Health;
• [15]Ministry of Health, Fiji. Strategic Plan 2011–2015. Fiji: Suva: Ministry of Health; 2011.
• [16]Ministry of Health: Country Health Plan. 19th Malaysia Plan 2011–2015. Putrajaya, Malaysia. Malaysia: Putrajaya: Mnistry of Health; 2011.
• [17]Ministry of Health:National Strategic Plan for Non-communicable Disease—Medium Term Strategic plan to further strengthen the cardiovascular disease and diabetes prevention and control Program in Malaysia (2010–2014). Malaysia: Putrajaya: Ministry of Health; 2010. [Non-communicable Disease Section, Disease Control Division]
• [18]Ministry of Health: Ministry of HealthHealth Sector Strategic Master Plan 2006–2015. Medium-term Expenditure Framework. Volume 1–4. Goverment of Mongolia: Ulaanbaatar: Ministry of Health; 2005.
• [19]Government of Mongolia: National Program on prevention and control of non-communicable diseases: 2006–2013. Ulaanbaatar: Government of Mongolia; 2007. [2007]
• [20]Department of Health and World Health Organization: Manual of Operations: Integrated non-communicable prevention and control program. Manila: Department of Health, Philippines; 2007.
• [21]Department of Health: Fourmula One (F1) for Health: National Health Development Plan (2006–2010). Philippines: Manila: Health Policy Development and Planning Bureau:Department of Health; 2006.
• [22]Department of Health, Republic of Philippines. The National Objectives of Health (2005–2010). Manila: Department of Health; 2005.
• [23]Alwan A, et al.: Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet 2010, 376(9755):1861-8. Epub 2010 Nov 10
• [24]Farrington JL, Stachenko S: Country capacity for non-communicable disease prevention and control in the WHO European Region: a preliminary Report. 2010. Health Organization Regional Office for Europe: Copenhagen; 2010.
• [25]World Health Organization: Global Health Observatory. Data on Health system response and capacity to address and respond to NCDs. Geneva, Switzerland: World Health Organization; http://www.who.int/gho/en/ webcite
• [26]Leowski J, Krishnan A: Capacity to control noncommunicable diseases in the countries of South-East Asia. Health Policy 2009, 92(1):43-8.
• [27]Lim MK, et al.: Prevention and Control of Chronic Noncommunicable Disease in Nine Pacific Rim Cities. Working paper series on health and demographic change in the Asia-Pacific. Stanford California, USA: Stanford University, Walter H. Shorenstein Asia-Pacific Research Center Asia Health Policy Program; 2010.
• [28]Baltazar JC, et al.: Prevalence and correlates of diabetes mellitus and impaired glucose tolerance among adults in Luzon, Philippines. Diabetes Res Clin Pract 2004, 64(2):107-15.
• [29]Burgdorf JR, Health and Medical Research in Japan: Health research Observatory. Prepared as part of RAND Europe’s Health Research Observatory Documented Briefing series. RAND; 2008.
• [30]HLSP: Health sector review (2003–2007). London: HLSP; 2007.
• [31]Economic Planning Unit: Tenth Malaysia Plan, 2011–2015. Putrajaya, Malaysia: Economic Planning Unit, Prime Minister's Department Putrajaya; 2010.
• [32]World Health Organization, International Diabetic Federation, and Secretariat for Pacific Countries: Western Pacific Declaration on Diabetes Mellitus. Kuala Lumpur: World Health Organization, International Diabetic Federation and Secretariat for Pacific Countries Kuala Lumpur; 2000.
• [33]World Health Organization: Health care decision-making in the Western Pacific Region. Diabetes and the Care Continuum in the Pacific Island Countries. Manila: WHO Western Pacific Regional Office; 2006.
• [34]Asaria P, et al.: Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007, 370(9604):2044-53. Epub 2007 Dec 11
• [35]Bolormaa T, et al.: Mongolia: Health system review. Health Systems in Transition 2007, 9(4):1-151.
• [36]Ritsatakis A, Makara P: Gaining Health Analysis of policy development in European countries for tackling noncommunicable diseases. Edited by Farrington JL, Geneau R, Pettersson B. Copenhagen: World Health Organization Regional Office for Europe; 2009.
• [37]Nugent RA, Fiegl AB: Where Have All the Donors Gone? Scarce Donor Funding for Non-Communicable Diseases. Center for Global Development Working Paper 228. Washington DC, USA: Center for Global Development; 2010.
• [38]Grundy J: Country-level governance of global health initiatives: an evaluation of immunization coordination mechanisms in five countries of Asia. Health Policy Plan 2009, 25(3):186-96. Epub 2009 Nov 19
• [39]Koivusalo M: The state of Health in All policies (HiAP) in the European Union: potential and pitfalls. J Epidemiol Community Health 2010, 64(6):500-3.